Key points are not available for this paper at this time.
The 2004 edition of guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research had been developed based on the results of a longitudinal study by subcommittee members and the results of an analysis of patients collected by the Subcommittee to Study Diagnostic Criteria for Corticosteroid-Induced Osteoporosis, together with evidence obtained overseas and in Japan at 2004. This guideline is now going to be revised. In this review, I want to introduce the history of guidelines on the management and treatment of glucocorticoid-induced osteoporosis and American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.
Tanaka et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: